Why do I have pale skin with kidney issues?

Pale skin with kidney issues often results from anemia caused by decreased erythropoietin production, affecting up to 90% of chronic kidney disease patients. Regular monitoring of kidney function markers and hemoglobin levels can help identify and manage this common complication.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

The Connection Between Kidney Disease and Pale Skin

If you've noticed your skin becoming unusually pale alongside kidney problems, you're experiencing one of the most common complications of kidney disease. This paleness, medically known as pallor, affects between 60-90% of people with chronic kidney disease (CKD) and becomes more prevalent as kidney function declines. The connection between your kidneys and skin color might seem surprising, but it reveals how interconnected our body systems truly are.

Your kidneys do far more than just filter waste from your blood. They produce essential hormones, regulate blood pressure, and play a crucial role in red blood cell production. When kidney function declines, these processes become disrupted, leading to visible changes in your appearance, including the characteristic paleness that many kidney patients experience.

Understanding Kidney-Related Anemia

The primary reason for pale skin in kidney disease is anemia, specifically a type called renal anemia or anemia of chronic kidney disease. Your kidneys produce a hormone called erythropoietin (EPO), which signals your bone marrow to produce red blood cells. When kidney function drops below about 45% of normal capacity, EPO production decreases significantly, leading to fewer red blood cells being made.

Stages of Kidney Disease and Anemia Risk

Anemia prevalence increases significantly as kidney function declines, with most Stage 5 CKD patients experiencing some degree of anemia.
CKD StageeGFR (mL/min/1.73m²)Anemia PrevalenceTypical Hemoglobin
Stage 1-2Stage 1-2>608-10%Usually normal
Stage 3Stage 330-5920-40%11-13 g/dL
Stage 4Stage 415-2950-60%9-11 g/dL
Stage 5Stage 5<1570-90%7-10 g/dL

Anemia prevalence increases significantly as kidney function declines, with most Stage 5 CKD patients experiencing some degree of anemia.

Red blood cells contain hemoglobin, the protein that gives blood its red color and carries oxygen throughout your body. With fewer red blood cells and less hemoglobin, your blood becomes less red, making your skin appear pale or even grayish. This isn't just a cosmetic concern; it indicates that your tissues aren't receiving adequate oxygen, which can affect every organ system in your body.

How Kidney Function Affects Red Blood Cell Production

Healthy kidneys produce approximately 90% of the body's erythropoietin. As kidney function declines, several factors contribute to anemia beyond just reduced EPO production. The buildup of uremic toxins in the blood can shorten the lifespan of red blood cells from the normal 120 days to as little as 60-90 days. Additionally, chronic inflammation associated with kidney disease can interfere with iron metabolism, making it harder for your body to use iron effectively in red blood cell production.

Understanding these mechanisms is crucial for proper treatment. Regular monitoring of kidney function markers like creatinine, BUN, and eGFR, along with hemoglobin levels and iron studies, can help identify anemia early and guide appropriate interventions.

Recognizing Symptoms Beyond Pale Skin

While pale skin is often the most visible sign, kidney-related anemia typically presents with multiple symptoms that can significantly impact quality of life. These symptoms often develop gradually, making them easy to dismiss as normal aging or stress-related fatigue.

  • Extreme fatigue and weakness, even with adequate rest
  • Shortness of breath during normal activities
  • Dizziness or lightheadedness, especially when standing
  • Cold hands and feet due to poor circulation
  • Difficulty concentrating or memory problems
  • Rapid or irregular heartbeat
  • Chest pain in severe cases
  • Headaches and sleep disturbances

The severity of these symptoms often correlates with the degree of anemia rather than the level of kidney dysfunction alone. Some people with mild kidney disease but severe anemia may feel worse than those with more advanced kidney disease but better-managed anemia.

When Pale Skin Indicates Serious Complications

Sudden onset of very pale or grayish skin, especially when accompanied by chest pain, severe shortness of breath, or confusion, requires immediate medical attention. These symptoms could indicate severe anemia with hemoglobin levels below 7 g/dL, which can strain your heart and other organs. In some cases, pale skin might also signal internal bleeding, a potential complication of advanced kidney disease due to platelet dysfunction.

Other Causes of Skin Changes in Kidney Disease

While anemia is the primary cause of pale skin in kidney disease, other factors can contribute to skin color and texture changes. Understanding these can help you and your healthcare provider develop a comprehensive treatment approach.

Uremic Frost and Toxin Buildup

In advanced kidney disease, waste products that would normally be filtered out accumulate in the blood. This condition, called uremia, can cause various skin changes. In severe cases, urea crystals can deposit on the skin surface, creating a white, frost-like appearance called uremic frost. While rare in modern healthcare settings, this represents a medical emergency requiring immediate dialysis.

More commonly, uremic toxins cause a yellowish or bronze discoloration of the skin, which combined with anemia-related pallor, can give the skin a distinctive grayish-yellow appearance. These toxins also contribute to severe itching (pruritus), affecting up to 40% of dialysis patients.

Nutritional Deficiencies

Kidney disease often leads to dietary restrictions and poor appetite, resulting in nutritional deficiencies that affect skin health. Iron deficiency, common in CKD patients, exacerbates anemia and pallor. Vitamin D deficiency, present in up to 80% of CKD patients, can cause skin to appear dull and contribute to the overall pale appearance. Protein-energy wasting, affecting 20-50% of dialysis patients, leads to muscle loss and thin, fragile skin that appears more translucent.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing and Monitoring Your Kidney Function

Early detection and regular monitoring of kidney function are essential for preventing or managing anemia and its associated symptoms. Several blood tests can provide valuable insights into your kidney health and help identify the underlying causes of pale skin.

Key biomarkers for kidney function include creatinine and blood urea nitrogen (BUN), which indicate how well your kidneys filter waste. The estimated glomerular filtration rate (eGFR), calculated from creatinine levels, provides the most accurate assessment of overall kidney function. For comprehensive monitoring of your metabolic health and kidney function, regular testing can help catch problems early when they're most treatable.

Essential Blood Tests for Diagnosis

To properly evaluate pale skin in the context of kidney disease, your healthcare provider will typically order a comprehensive metabolic panel along with a complete blood count (CBC). The CBC reveals hemoglobin levels, with values below 13 g/dL in men or 12 g/dL in women indicating anemia. Iron studies, including ferritin, transferrin saturation, and total iron-binding capacity, help determine if iron deficiency contributes to the anemia.

Additional tests might include vitamin B12 and folate levels, as deficiencies in these nutrients can worsen anemia. Inflammatory markers like C-reactive protein (CRP) can indicate chronic inflammation that interferes with red blood cell production. Parathyroid hormone (PTH) levels often become elevated in kidney disease and can contribute to anemia by affecting bone marrow function.

Treatment Options for Kidney-Related Anemia

Managing pale skin caused by kidney disease requires treating the underlying anemia. Treatment approaches vary based on the severity of kidney dysfunction and the degree of anemia, but typically involve a combination of medications and lifestyle modifications.

Erythropoiesis-Stimulating Agents (ESAs)

ESAs are synthetic versions of erythropoietin that stimulate red blood cell production. These medications, including epoetin alfa and darbepoetin alfa, are typically started when hemoglobin falls below 10 g/dL in CKD patients not on dialysis. The goal is usually to maintain hemoglobin between 10-11.5 g/dL, as higher targets have been associated with increased cardiovascular risks. Response to ESA therapy typically takes 2-6 weeks, and doses are adjusted based on regular hemoglobin monitoring.

Iron Supplementation

Most CKD patients with anemia require iron supplementation, either oral or intravenous. Oral iron is often poorly absorbed and can cause gastrointestinal side effects, so intravenous iron is frequently preferred, especially for dialysis patients. Target ferritin levels are typically 200-500 ng/mL, with transferrin saturation above 20%. Regular monitoring ensures adequate iron stores without iron overload.

For those interested in tracking their iron status and overall health markers at home, comprehensive testing programs can provide valuable insights into treatment effectiveness. If you want to better understand your body's response to treatment and optimize your health management, consider exploring testing options that include ferritin and other essential biomarkers.

Lifestyle Modifications to Support Kidney Health

While medical treatment is essential for managing kidney-related anemia, lifestyle modifications can significantly impact both kidney function and anemia symptoms. These changes can slow kidney disease progression and improve your body's ability to produce and maintain healthy red blood cells.

  • Follow a kidney-friendly diet low in sodium, phosphorus, and potassium as recommended by your healthcare provider
  • Maintain adequate protein intake while avoiding excess, typically 0.6-0.8 g/kg body weight for CKD patients not on dialysis
  • Stay hydrated appropriately based on your kidney function and any fluid restrictions
  • Exercise regularly to improve cardiovascular health and combat fatigue
  • Manage blood pressure through medication adherence and lifestyle changes
  • Control blood sugar if you have diabetes, as it's the leading cause of kidney disease
  • Avoid NSAIDs and other medications that can harm kidney function
  • Quit smoking, as it accelerates kidney disease progression

Working with a renal dietitian can help you navigate dietary restrictions while ensuring adequate nutrition to support red blood cell production. Many people find that even small improvements in diet and exercise can lead to noticeable improvements in energy levels and skin appearance.

Looking Forward: Managing Your Health Long-term

Living with kidney disease and its complications like anemia requires ongoing monitoring and adjustment of treatment strategies. The good news is that with proper management, many people with kidney-related anemia see significant improvements in their symptoms, including the return of healthier skin color.

Regular follow-up appointments every 3-6 months allow for timely adjustments to your treatment plan. During these visits, your healthcare provider will monitor kidney function, hemoglobin levels, iron stores, and other relevant markers. Keeping a symptom diary can help identify patterns and treatment responses.

For those who want to take a more active role in monitoring their health, uploading your existing blood test results for analysis can provide personalized insights and help you track changes over time. This free service can help you better understand your lab results and identify trends that might otherwise go unnoticed.

Remember that pale skin, while concerning, is a treatable symptom of kidney disease. With appropriate medical care, lifestyle modifications, and regular monitoring, you can manage anemia effectively and improve both your appearance and overall quality of life. The key is early detection, consistent treatment, and working closely with your healthcare team to optimize your kidney health and address complications as they arise.

References

  1. Babitt JL, Eisenga MF, Haase VH, et al. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney International. 2021;99(6):1280-1295.[Link][DOI]
  2. Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9(1):e84943.[Link][PubMed][DOI]
  3. Portolés J, Martín L, Broseta JJ, Cases A. Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents. Frontiers in Medicine. 2021;8:642296.[Link][PubMed][DOI]
  4. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron Deficiency Anemia in Chronic Kidney Disease. Acta Haematologica. 2019;142(1):44-50.[PubMed][DOI]
  5. Fishbane S, Spinowitz B. Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. American Journal of Kidney Diseases. 2018;71(3):423-435.[Link][PubMed][DOI]
  6. Khanna R. Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome. Missouri Medicine. 2011;108(1):33-36.[PubMed]

Was this article helpful?

Frequently Asked Questions

How can I test my kidney function at home?

You can test your kidney function at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive kidney function markers like creatinine, BUN, and eGFR, along with other metabolic health indicators.

What hemoglobin level indicates anemia in kidney disease?

Anemia is typically diagnosed when hemoglobin falls below 13 g/dL in men or 12 g/dL in women. In kidney disease, treatment often begins when levels drop below 10 g/dL, though your doctor may recommend intervention earlier based on symptoms.

Can kidney-related pale skin be reversed?

Yes, pale skin caused by kidney-related anemia often improves with proper treatment. ESA therapy and iron supplementation can restore hemoglobin levels within 2-6 weeks, though ongoing treatment is usually necessary to maintain improvements.

What other skin problems occur with kidney disease?

Besides pallor, kidney disease can cause itching (affecting 40% of dialysis patients), dry skin, bruising easily, yellowish discoloration from uremic toxins, and in severe cases, uremic frost from crystallized waste products on the skin.

When should I see a doctor about pale skin?

Seek immediate medical attention if pale skin is accompanied by chest pain, severe shortness of breath, rapid heartbeat, or confusion. Schedule an appointment if you notice gradual skin color changes along with fatigue, weakness, or known kidney problems.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details